IDiyas

For the Inventor, By the Inventor

Cedar Knolls, NJ, United States of America

Chung-Chen Wei

USPTO Granted Patents = 15

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 88(Granted Patents)


Location History:

  • Cedar Knoll, NJ (US) (1984)
  • Cedar Knolls, NJ (US) (1984 - 1996)
  • Foster City, CA (US) (2002 - 2005)

Company Filing History:

goldMedal15 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents

Years Active: 1984-2005

Loading Chart...
15 patents (USPTO):
1. 6838558 - Pyrazolobenzodiazepines (2005-01-04),
2. 6440959 - Pyrazolobenzodiazepines (2002-08-27),
3. 5523400 - Cephalosporin antibiotics (1996-06-04),
4. 5329002 - Antibacterial cephalosporin compounds (1994-07-12),
5. 5189157 - Antibacterial cephalosporin compounds (1993-02-23),
6. 5162523 - Cephalosporin antibacterial compounds (1992-11-10),
7. 5159077 - Penam antibacterial compounds (1992-10-27),
8. 5112967 - Process for synthesizing antibacterial cephalosporin compounds (1992-05-12),
9. 4801704 - Methylene penam and derivatives thereof (1989-01-31),
10. 4663469 - 4-hydroxy-l-threoninamides (1987-05-05),
11. 4605744 - Imidazole derivatives (1986-08-12),
12. 4537969 - Imidazole derivatives (1985-08-27),
13. 4502994 - Enantiomeric synthesis of (1985-03-05),
14. 4461726 - Desulfurization of penicillins to prepare azetidinones (1984-07-24),
15. 4431653 - Penicillanic acid derivatives (1984-02-14),

Title: **Innovator Profile: Chung-Chen Wei**

Introduction

Chung-Chen Wei is a prominent inventor based in Cedar Knolls, New Jersey, recognized for his contributions to the field of pharmaceutical chemistry. With 15 patents to his name, Wei has significantly advanced the science of medicinal compounds and their applications in oncology.

Latest Patents

Wei's latest patents include novel pyrazolobenzodiazepines, compounds that are designed to assist in the treatment and control of solid tumors. These innovative compounds are characterized by their unique chemical formula, which facilitates their role in cancer therapies. The advancements offered by these pyrazolobenzodiazepines underscore Wei's commitment to enhancing the efficacy of treatments for patients battling cancer.

Career Highlights

Chung-Chen Wei has made notable strides in his career at Hoffmann-La Roche Inc., where he has developed several key inventions that impact the pharmaceutical landscape. His dedication to research and development has positioned him as a leader within his field, consistently pushing the boundaries of what is possible in drug formulation and therapy.

Collaborations

Throughout his career, Wei has collaborated with accomplished peers, including Manfred Weigele and Dennis D Keith. Their combined expertise has fostered an environment of innovation, allowing for the exploration of new ideas and the advancement of research that benefits both the scientific community and patients worldwide.

Conclusion

Chung-Chen Wei stands out as an influential inventor whose work with pyrazolobenzodiazepines reflects a deep understanding of medicinal needs. His contributions not only emphasize the importance of innovation in medicine but also inspire future generations of researchers and inventors to pursue groundbreaking discoveries in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…